- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06260332
젊은 히스패닉 유방암 생존자의 통증 개선을 위한 신체활동 중재
회복을 향한 움직임: 젊은 히스패닉계 여성의 암 유방 수술 후 지속적인 통증을 줄이기 위한 신체 활동 중재
This clinical trial tests whether increased activity throughout the day can improve the chronic pain and associated symptoms that breast cancer survivors may experience after surgery. Staying active is a key factor of one's physical, mental, and social health and well-being. Moving more could also reduce pain and associated stress, anxiety, or depression. Using a fitness tracker may help patients to move around more, whether or not they choose to exercise. Information gathered from this study may help researchers learn how the use of a Fitbit tracker with health coaching may improve physical activity and reduce pain in young, Hispanic breast cancer survivors.
연구 개요
상세 설명
PRIMARY OBJECTIVE:
I. To assess the feasibility of a physical activity intervention in young, Hispanic women with chronic post-operative pain after breast surgery for invasive breast cancer, termed post breast surgery pain syndrome (PBSPS) for this study.
SECONDARY OBJECTIVES:
I. To assess the preliminary efficacy of a physical activity intervention in decreasing pain in young, Hispanic women with PBSPS.
II. To assess the preliminary efficacy of the physical activity intervention in increasing physical activity and improving health-related quality of life (hrQOL).
OUTLINE:
Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
New Mexico
-
Albuquerque, New Mexico, 미국, 87106
- University of New Mexico Comprehensive Cancer Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Women who have completed surgery for invasive breast cancer >= 6 months prior to enrollment
- Any breast surgery (lumpectomy or mastectomy)
- Baseline low to moderate activity level (exercise less than 120 minutes a week)
- PBSPS defined as pain in the area of breast surgery of at least moderate intensity (>= 4 on a scale of 1-10), located in the ipsilateral beast/chest wall, axilla or arm, lasting at least 6 months, and occurring at least 50% of the time
- Self-identified as Hispanic/Latinx
- Age, >= 18 and =< 60 years
- Endocrine therapy and ovarian suppression is allowed
Exclusion Criteria:
- Metastatic or locally recurrent disease with no option for curative intent treatment
- Meeting or exceeding physical activity guidelines (> 150 minutes per week of moderate-intensity exercise)
- Unable to speak, read, and understand English or Spanish
- Severe impairments (in seeing or hearing) or pre-existing medical limitations for engaging in daily physical activity. This is defined as the ability to walk 3 blocks without stopping to rest and without using an assistive device
- Unwilling to use a study provided smartphone (if do not already own one) and wear activity trackers/monitors
- Adults not able to consent are excluded from participation
- Based on the age criteria (18 years and older), individuals who are not yet adults (infants, children, teenagers) may not participate in this study due to the same age criteria above
- Pregnant women
- Prisoners may not participate in this study as this is a study of free-living individuals
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Supportive Care (Fitbit)
Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11. |
Wear Fitbit, Use Fitbit application, Receive educational materials, attend coaching calls, Ancillary studies
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Recruitment rate (Feasibility)
기간: Up to 1 year
|
This study will be considered feasible with the recruitment of 25 breast cancer patients. |
Up to 1 year
|
|
Retention rate (Feasibility)
기간: Up to 12 weeks
|
This study will be considered feasible if 80% of patients complete all pre and post assessments. |
Up to 12 weeks
|
|
Adherence rate (Feasibility)
기간: Up to 12 weeks
|
This study will be considered feasible if participants complete at least 4 of 5 health coaching sessions (80%). |
Up to 12 weeks
|
|
Incidence of adverse events
기간: Up to 12 weeks
|
Safety will be tracked by the study team. |
Up to 12 weeks
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in chronic post-surgical pain
기간: At 13 weeks
|
Reducing chronic post-surgical pain will be measured using the Defense and Veterans Pain Rating Scale. Will also be assessed by Bodily Threat Monitoring Scale and pain self-efficacy questionnaire. Will summarize change scores with means and standard deviations, or medians and interquartile ranges, and obtain 95% confidence intervals. Will perform one-sided paired t-tests, or Wilcoxon signed rank tests. |
At 13 weeks
|
|
Change in physical activity
기간: At 13 weeks
|
Increasing physical activity will be measured using accelerometry data using the activePAL activity monitor. Will summarize change scores with means and standard deviations, or medians and interquartile ranges, and obtain 95% confidence intervals. Will perform one-sided paired t-tests, or Wilcoxon signed rank tests. |
At 13 weeks
|
|
Change in health-related quality of life (hrQOL)
기간: At 13 weeks
|
Improvement in hrQOL will be measured using Patient-Reported Outcomes Measurement Information System surveys. Will summarize change scores with means and standard deviations, or medians and interquartile ranges, and obtain 95% confidence intervals. Will perform one-sided paired t-tests, or Wilcoxon signed rank tests. |
At 13 weeks
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Jacklyn M Nemunaitis, MD, New Mexico Cancer Research Alliance
- 수석 연구원: Cindy K Blair, Ph.D., New Mexico Cancer Research Alliance
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- INST UNM 2302
- 23-293 (기타 식별자: UNM HSC IRB)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .